Clinically, the elevated systemic levels of IL-6 and TNF-α are particularly concerning, since these pro-inflammatory molecules are directly associated with insulin resistance and hyperinsulinemia, which are common in individuals with obesity. The gene discussed is IL6; the disease is hyperinsulinism.